Immunotherapy Using Dendritic Cells against Multiple Myeloma: How to Improve?

Multiple myeloma (MM) is a good target disease in which one can apply cellular immunotherapy, which is based on the graft-versus-myeloma effect. This role of immune effector cells provides the framework for the development of immune-based therapeutic options that use antigen-presenting cells (APCs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen-Pham, Thanh-Nhan, Lee, Yoon-Kyung, Kim, Hyeoung-Joon, Lee, Je-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312256/
https://www.ncbi.nlm.nih.gov/pubmed/22481968
http://dx.doi.org/10.1155/2012/397648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312256/
https://www.ncbi.nlm.nih.gov/pubmed/22481968
http://dx.doi.org/10.1155/2012/397648

Ejemplares similares